I've had it! My patience is worn out.Fletcher must go! Shame on the Board of Directors for not booting him out by now! Fletcher's lame excuse during the conference call when asked about whether the company should search for a new CEO, replied by saying that it would be difficult to find a qualified candidate with pharma experience to replace him who would be willing to take on the job at this time. Nonsense! Did anyone else also sense the abrupt and unhappy tone by management at the end of the conference call after the question was asked about Fletcher's credibility? They couldn't wait to get off the conference! Either get a qualified CEO to run the company or sell the company to a management team that is capable and experienced in moving a biotech company forward. My gut is that management is pinning its hopes on India approving Oralyn later this year, and that the stock will move up on that news, let's say back to its most recent high of .32...and then implmenting a reverse stock split of 10-to-1 to enabling it to again be listed on the NASQ or American Exchange. Also, if no pharma is interested in buying Antigen right now, is management naive enough to believe that we, as investors and existing shareholders, after all we've been through, will actually be stupid enough to buy new shares of Antigen with the promise of so called "dividends"? It's not enough to have promising products in the pipeline if the CEO has no credibility in the marketplace. I'm also tired of Fletcher repeatedly blaming the past management for all of Generex's problems. That's just a cop out for his incompetence. He's had enough time now to make a difference and he must go, and so should any past or newer Board members whose responsibility is to protect shareholders...not the CEO!
"would be difficult to find a qualified candidate with pharma experience to replace him who would be willing to take on the job at this time. '
Michael R. Taylor=is the Deputy Commissioner for Foods at the United States Food and Drug Administration=He received a law degree from the University of Virginia= In 1981he went into private practice at King & Spalding, a law firm, one client of which was the biotechnology company Monsanto!!!=Between 1996 and 2000, after briefly returning to King & Spalding, he then returned to Monsanto to become Vice President for Public Policy=GMO Virus: Silent Killer!!
Boy this country fakked!
"If your team doesn't make it to the superbowl, you don't fire the team......you fire the coach"
You fire the dead meat as well..do you?Or you renew the contract with the nonproductive players..like Fellows?And if your team is bankrupt,you buy cheaper players..do you?
"My gut is that management is pinning its hopes on India approving Oralyn later this year"
I though the same thing.That is why they ask for more shares (to buy time) and have a meeting sooo early.They gave up on Oral Lyn,AE and they just hope the market will pump the price up until the India news (IF ever)
You mean they are hoping for an infinite spin while infinetly looping and then have the oudacity too try a r\s during it, balls what a wham bam bang up job to have. This must be how they plan on treating 22nd century investors in this country!